To the Editor:
Asthma is the most common chronic disease in children and comorbid environmental allergies have prognostic relevance1. Short chain fatty acids (SCFA), including acetic acid, butyric acid and propionic acid, are metabolites produced by intestinal microbes through fermentation of dietary fiber2. Immune-modulating properties of SCFA are numerous and include increasing T regulatory cell differentiation3. Fecal SCFA during infancy are associated with reduced risk of asthma with allergic sensitization later in life4–6. In mouse models, SCFA supplementation during pregnancy leads to reduced allergic airway disease in offspring7,8 and in 40 mother-child pairs, low maternal serum acetic acid was associated with increased cough or wheeze in infant offspring7. Other than this, the association of SCFA during pregnancy and offspring risk of asthma and/or allergy has not been reported.
We hypothesized that SCFA during pregnancy, measured via mass spectrometry, are associated with reduced asthma and allergy in offspring. Methods are detailed in the Online Repository. Subjects were 150 mother-child pairs who participated in the Vitamin D Antenatal Asthma Reduction Trial (VDAART), a randomized controlled trial of Vitamin D during pregnancy for prevention of asthma ( NCT00920621, Tables E1–3). The study protocol was approved by the institutional review boards at each participating institution and at Brigham and Women’s Hospital. All participants provided written informed consent.
Participating mothers provided stool samples during the 3rd trimester of pregnancy in which SCFA were measured by liquid chromatography with tandem mass spectrometry. We examined both absolute concentrations of SCFA and relative concentrations of each SCFA as a proportion of all measured SCFA. In general, the ratio of fecal acetic acid:butyric acid:propionic acid is approximately 60:20:20. Deviations from this ratio reflect differences in bacterial composition and other exposures. For example, relative acetic acid has repeatedly been associated with breastfeeding and associated gut microbes9. Additionally, abundance of one SCFA could influence the functions of others via mechanisms such as competition at common G-protein coupled receptors2 and effects on bioavailability. So, relative proportions may be more important in some contexts than absolute concentrations.
Clinical outcomes in offspring were ascertained at age 6 years. Asthma/wheeze was based on parental report of physician-diagnosed asthma, recurrent wheeze and asthma medication use. Allergic sensitization was defined by serum specific IgE ≥ 0.35 kU/L to at least one environmental or food allergen. Hay fever was defined by parental report of physician-diagnosed allergic rhinitis. Seventy (47% of) children had asthma/wheeze, 38 (48%) had allergic sensitization and 54 (40%) had hay fever. Seventeen (21%) had both asthma/wheeze and sensitization and 33 (24%) had both asthma/wheeze and hay fever.
In logistic regression analyses, neither absolute nor relative maternal fecal SCFA were associated with the individual outcomes of asthma/wheeze, sensitization or hay fever (Figure 1, Table E4). However, relative, but not absolute, acetic acid concentration was inversely associated with asthma/wheeze with sensitization (odds ratio (OR) for 10% increase in relative acetic acid concentration 0.46, 95% confidence interval (CI) 0.22–0.94, p=0.036) (Figure 2, Table E4). A similar non-significant inverse association was seen between maternal fecal relative acetic acid and asthma/wheeze with hay fever (OR 0.63, 95% CI 0.37–1.05, p=0.077) (Figure 2). Permutation testing yielded similar results (Table E5 in the Online Repository).
As SCFA are products of microbial fermentation of dietary fiber, we investigated the maternal diet and fecal microbiome, hypothesizing that these factors correlate with fecal SCFA and offspring outcomes. Maternal dietary fiber intake was estimated from food frequency questionnaires from the 3rd trimester. In adjusted linear regression analyses, fiber intake was positively associated with total SCFA (beta for a 1-unit increase in log-transformed dietary fiber nutrient density=0.26, 95% CI 0.02–0.44, p=0.035) and with absolute concentrations of acetic acid (beta=0.30, 95% CI 0.07–0.53, p=0.011) and propionic acid (beta=0.26, 95% CI 0.01–0.51, p=0.045) (Table E6). Fiber intake was positively but non-significantly associated with relative acetic acid (beta=0.03, 95% CI −0.0004–0.07, p=0.052). However, fiber intake during pregnancy was not associated with offspring outcomes (Table E7 in the Online Repository), and this may be because dietary fiber contributes to offspring disease risk only in combination with relevant intestinal microbes.
Bacterial 16S rRNA sequencing was performed on the same stool samples used for SCFA profiling in 114 of the 150 participating mothers. Shannon index, an alpha diversity metric, was not associated with SCFA (Table E8). Bray-Curtis dissimilarity, a beta diversity measure of taxonomic composition, was associated with relative and absolute concentrations of all three SCFA (all p < 0.05, Table E8), providing evidence that specific taxa contribute to production of SCFA. However, Bray-Curtis dissimilarity was not associated with offspring outcomes (Table E9).
In negative binomial regression analyses, four taxa were associated with relative concentrations of all three SCFA (FDR < 0.20, Table E10). Of these, Eubacterium dolichum and Streptococcus anginosus demonstrated directionally consistent associations with offspring asthma/wheeze with sensitization (log2fold change 1.7 and −1.2; p=0.002 and 0.045, respectively, Table E11, Figure E1). These species belong to genera known to produce SCFA2, though given the broad array of species that produce SCFA, likely represent a small subset of those with relevance to offspring health. From these analyses, we concluded that specific taxa may impact relative acetic acid in the gut during pregnancy, which may in turn modify risk of atopic asthma/wheeze in offspring.
In summary, we found that relative concentration of the SCFA acetic acid during pregnancy is associated with reduced asthma/wheeze with allergic sensitization in offspring. A similar non-significant association was seen between relative acetic acid during pregnancy and asthma/wheeze with hay fever in offspring. Though prior literature suggests that maternal fecal SCFA may influence child outcomes via mechanisms including epigenetic modification, it is possible that maternal fecal SCFA also correlate with child diet and microbiome composition and the latter may have more causal significance. If findings are replicated, this study supports the use of microbiome-targeted therapies, potentially in combination with dietary fiber, to increase SCFA production as therapeutic strategies to prevent asthma and atopy in offspring.
This analysis is subject to limitations. Food frequency questionnaire data are subject to presumably non-differential measurement bias, though the significant correlations we saw between fiber intake and fecal SCFA provide some degree of validation for both measures. Both dietary intake and relevant elements of the gut microenvironment may have varied over pregnancy, and we assessed only one time point in the third trimester. Our sample size was limited as data were not available for all VDAART participants, and though our findings are biologically plausible, they require replication in an independent sample.
Supplementary Material
Clinical Implications:
Mothers with higher fecal acetic acid, compared to other short-chain fatty acids, during pregnancy were less likely to have offspring with atopic asthma. If replicated, findings support use of microbiome-targeted treatments during pregnancy to increase fecal acetic acid.
Funding:
VDAART was funded by U01HL091528 from the National Heart, Lung, and Blood Institute. Additional funding came from NIH grants R01HL108818, R01HL123915, R01HL141826-01, 5T32HL007427-34 and ECHO grant OD023268.
Footnotes
Conflict of Interest Statement:
AAL has received author royalties from UpToDate, Inc. and consultant fees from AstraZeneca, LP. STW has received royalties from UpToDate, Inc. LBB participates on the Data Safety Monitoring Board of DBV Technologies. AB holds stock from DBV Technologies. RSZ is a consultant for AstraZeneca, DBV Technologies, Genentech, Inc., GlaxoSmithKline, Novartis, Patara Pharma, Regeneron, TEVA Pharmaceuticals, and Theravance Biopharma, and has received research support from Aerocrine, AstraZeneca, Genentech, Inc., GlaxoSmithKline, NHLBI, MedImmune, and Merck. JL-S is a consultant to Metabolon Inc. GTO is a co-investigator on a grant from Janssen Pharmaceuticals to Boston University that funds a study of the pathogenesis of chronic obstructive pulmonary disease. KL-S, RSK, MS, NL, SRS and DRG have nothing to disclose.
Trial Registration: ClinicalTrials.gov NCT00920621
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
REFERENCES
- 1.Matricardi PM, Illi S, Grüber C, Keil T, Nickel R, Wahn U, et al. Wheezing in childhood: Incidence, longitudinal patterns and factors predicting persistence. Eur Respir J 2008;32:585–92. [DOI] [PubMed] [Google Scholar]
- 2.Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell 2016;165:1332–45. [DOI] [PubMed] [Google Scholar]
- 3.Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013;504:451–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Arrieta M-C, Stiemsma LT, Dimitriu PA, Thorson L, Russell S, Yurist-Doutsch S, et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med 2015;7:307ra152–307ra152. [DOI] [PubMed] [Google Scholar]
- 5.Arrieta MC, Arévalo A, Stiemsma L, Dimitriu P, Chico ME, Loor S, et al. Associations between infant fungal and bacterial dysbiosis and childhood atopic wheeze in a nonindustrialized setting. J Allergy Clin Immunol 2018;142:424–434.e10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Roduit C, Frei R, Ferstl R, Loeliger S, Westermann P, Rhyner C, et al. High levels of Butyrate and Propionate in early life are associated with protection against atopy. Allergy Eur J Allergy Clin Immunol 2018. [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
- 7.Thorburn AN, McKenzie CI, Shen S, Stanley D, MacIa L, Mason LJ, et al. Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat Commun. 2015;6:7320. [DOI] [PubMed] [Google Scholar]
- 8.Nakajima A, Kaga N, Nakanishi Y, Ohno H, Miyamoto J, Kimura I, et al. Maternal High Fiber Diet during Pregnancy and Lactation Influences Regulatory T Cell Differentiation in Offspring in Mice. J Immunol 2017;199:3516–3524. [DOI] [PubMed] [Google Scholar]
- 9.Bridgman SL, Azad MB, Field CJ, Haqq AM, Becker AB, Mandhane PJ, et al. Fecal Short-Chain Fatty Acid Variations by Breastfeeding Status in Infants at 4 Months: Differences in Relative versus Absolute Concentrations. Front Nutr 2017;4:11. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.